Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker: F2G, Candid & more
Welcome to Fierce Biotech's Fundraising Tracker, 2024's version.
Gabrielle Masson
,
Annalee Armstrong
,
Darren Incorvaia
,
Max Bayer
Sep 17, 2024 7:00am
F2G raises $100M for 2nd attempt to get new antifungal to market
Sep 12, 2024 8:58am
Bain unveils $3B fund for life science companies
Sep 10, 2024 11:20am
Lilly-backed Superluminal speeds toward the clinic with $120M
Sep 9, 2024 7:00am
ArsenalBio raises $325M, pivots away from former lead asset
Sep 4, 2024 8:00am
Navigator raises $100M to develop new autoimmune pipeline
Aug 27, 2024 8:50am